Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
McKinsey
Colorcon
Express Scripts
Medtronic

Last Updated: June 25, 2022

Litigation for LACOSAMIDE


✉ Email this page to a colleague

« Back to Dashboard

US Court Litigation for LACOSAMIDE

Glossary
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
RE38,551 UCB Inc. v. Accord Healthcare Inc. See Plans and Pricing 2013-07-10 2016-09-02 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
RE38,551 UCB Inc. v. Glenmark Generics Inc. USA See Plans and Pricing 2013-07-10 2014-06-23 35:271 Patent Infringement District Court, D. Delaware Defendant See Plans and Pricing
RE38,551 UCB, Inc. v. Hetero USA Inc. See Plans and Pricing 2016-06-17 2018-09-20 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
RE38,551 See Plans and Pricing See Plans and Pricing 2016-11-29 2020-01-20 35:271 Patent Infringement District Court, D. Delaware Defendant See Plans and Pricing
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Subscribe to access the full database, or Try it Free

Patent Trial and Appeal Board Cases for LACOSAMIDE

Glossary
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
RE38,551 ACTAVIS, INC. See Plans and Pricing 2014-07-10 07-10-2014 Research Corporation Technologies, Inc. Inter partes review See Plans and Pricing 01-09-2015 Harold Kohn See Plans and Pricing
RE38,551 Argentum Pharmaceuticals LLC See Plans and Pricing 2015-11-23 11-23-2015 Research Corporation Technologies, Inc. Inter partes review See Plans and Pricing 05-23-2016 Harold Kohn See Plans and Pricing
RE38,551 Mylan Pharmaceuticals Inc. See Plans and Pricing 2016-05-25 05-25-2016 Research Corporation Technologies, Inc. Inter partes review See Plans and Pricing 10-24-2016 Harold Kohn See Plans and Pricing
RE38,551 Breckenridge Phamaceutical, Inc. See Plans and Pricing 2016-06-21 06-21-2016 Inter partes review See Plans and Pricing 10-24-2016 Harold Kohn See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Subscribe to access the full database, or Try it Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Baxter
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group